Use of glp-1r / gipr double-target agonist in preparing animal drug
Patent Information
- Application Number
- HK62026127160
- Authority / Receiving Office
- HK · HK
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-11-22
- Filing Date
- 2026-08-06
- Publication Date
- 2026-10-09
- Estimated Expiration
- 2044-11-20
Smart Images

Figure 00000000_0000_ABST
Abstract
Description
(19) State Intellectual Property Office (12) Invention Patent Application (10) Application Publication Number (43) Application Publication Date (21) Application Number 202480073954.7 (22) Application Date 2024.11.21 (66) Domestic Priority Data 202311565075.X 2023.11.22 CN (85) PCT International Application Entering National Phase Date 2026.05.21 (86) PCT International Application Application Data PCT / CN2024 / 133548 2024.11.21 (87) PCT International Application Publication Data WO2025 / 108381 ZH 2025.05.30 (71) Applicant Hangzhou Sino-American East China Pharmaceutical Co., Ltd. Address 310011 No. 866, Moganshan Road, Gongshu District, Hangzhou City, Zhejiang Province (72) Inventors: Zhang Nan, Jiang Chunhua, Liu Dongzhou, Teng Li (74) Patent Agency: Beijing Yongxin Tongchuang Intellectual Property Agency Co., Ltd. 11376 Patent Attorney: Luan Xingming (51) Int.Cl. A61K 38 / 16 (2006.01) C07K 14 / 00 (2006.01) A61P 3 / 10 (2006.01) A61P 3 / 04 (2006.01) A61P 9 / 10 (2006.01) A61P 9 / 00 (2006.01) (54) Invention Title: Use of GLP-1R / GIPR Dual-Target Agonist in the Preparation of Animal Drugs (57) Abstract: Use of GLP-1R / GIPR dual-target agonist compounds in the preparation of drugs for the prevention or treatment of diseases in non-primates and non-rodents. CN 122396499 A 2026.07.14 CN 1 22 39 64 99 A Abstract Use of a GLP-1R / GIPR double-target agonist compound in preparing a drug for preventing or treating diseases in non-primate and non-rodent animals.